Alan H. Auerbach
2020
In 2020, Alan H. Auerbach earned a total compensation of $4.4M as President and Chief Executive Officer at Puma Biotechnology, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $417,756 |
|---|---|
| Option Awards | $1,574,009 |
| Salary | $834,276 |
| Stock Awards | $1,574,004 |
| Other | $13,782 |
| Total | $4,413,827 |
Auerbach received $1.6M in option awards, accounting for 36% of the total pay in 2020.
Auerbach also received $417.8K in non-equity incentive plan, $834.3K in salary, $1.6M in stock awards and $13.8K in other compensation.
Rankings
In 2020, Alan H. Auerbach's compensation ranked 2,561st out of 13,090 executives tracked by ExecPay. In other words, Auerbach earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,561 out of 13,090 | 80th |
Division Manufacturing | 979 out of 5,617 | 83rd |
Major group Chemicals And Allied Products | 358 out of 2,248 | 84th |
Industry group Drugs | 308 out of 1,948 | 84th |
Industry Pharmaceutical Preparations | 224 out of 1,453 | 85th |
Source: SEC filing on April 26, 2021.
Auerbach's colleagues
We found four more compensation records of executives who worked with Alan H. Auerbach at Puma Biotechnology in 2020.
2020
Jeff Ludwig
Puma Biotechnology
Chief Commercial Officer
2020
Richard Bryce
Puma Biotechnology
B, MRCGP and MFPM Former Chief Medical and Scientific Officer
2020
Douglas Hons
Puma Biotechnology
Senior Vice President, Regulatory Affairs, Medical Writing and Project Management
2020
Maximo Nougues
Puma Biotechnology